Active · per the CBE, 16 September 2026

ESPIDEC

BE0896802612

Rechtspersoon Private limited company 1 establishment

ESPIDEC is a pharmacy in Sint-Genesius-Rode. Private Limited, started on 31 March 2008, 1 establishment.

Zoniënwoudlaan 361, 1640 Sint-Genesius-Rode

Behind the company: PHARDEX BVBA BV.

Active for

18 year, 5 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Shrinking team NBB

    FTE fell two years in a row, from 3.7 to 3.3.

Financials

Financial year 2025

ESPIDEC from Sint-Genesius-Rode, company number BE0896802612, closed financial year 2025 with a result of € 227,994 after tax. For that financial year ESPIDEC recorded a gross margin of € 671,883 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 200,421 to € 227,994. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Growing

€ 1.4 million

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 227,994

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 134,391

▼ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

9 % of the profit went to the shareholders, mostly to PHARDEX (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

3.3

▼ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 242,168

€ 73,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 31,317

▼ 7% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go

€ 757,408

▼ 10% vs 2024

€ 137,653 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 75,938

▼ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 49,596

▲ 5% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 672,466 € 490,996 € 645,853 € 671,883 ▲ 4%
Profit after taxes € 282,176 € 122,884 € 200,421 € 227,994 ▲ 14%
Equity € 868,092 € 990,976 € 1,171,397 € 1,379,391 ▲ 18%
Total debts € 1,234,533 € 1,168,449 € 1,012,715 € 918,441 ▼ 9%
Cash € 231,091 € 176,321 € 216,211 € 134,391 ▼ 38%
Land & buildings € 492,569 € 467,536 € 442,503 € 417,470 ▼ 6%
Retained profit € 861,892 € 984,776 € 1,165,197 € 1,373,191 ▲ 18%
Dividend € 0 € 0 € 20,000 € 20,000
Bank debt € 1,100,012 € 970,690 € 841,544 € 757,408 ▼ 10%
Balance sheet total € 2,102,625 € 2,159,425 € 2,184,112 € 2,297,832 ▲ 5%
Employees (FTE) 4.8 3.7 3.6 3.3 ▼ 0.3

Key figures of ESPIDEC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ESPIDEC?

What happened at ESPIDEC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 227,994 (▲ 14% vs 2024). Source: NBB ↗
  • PHARDEX BVBA BV became a director. NBB
  • New establishment in Sint-Genesius-Rode. KBO
  • Start of the company according to the CBE. KBO

In short

From € 282,176 profit in 2022 to € 227,994 profit in 2025.

Paid € 235,319 in corporate taxes since 2022.

Best year ever: 2022, with € 282,176 profit.

On average € 203,600 of value added per employee in 2025.

Management

PHARDEX 100%

The stake of PHARDEX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

ESPIDEC

Behind ESPIDEC is PHARDEX BVBA BV. The shares are held by PHARDEX (100%).

See the full network in the app

Directors

According to the 2025 annual accounts

PHARDEX BVBA BV

Director

since 2018

Shareholders

PHARDEX

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Zoniënwoudlaan 361

1640 Sint-Genesius-Rode

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0896.802.612
VAT number
BE 0896.802.612
Registered office
Zoniënwoudlaan 361, 1640 Sint-Genesius-Rode
Names & denominations
ESPIDEC
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
31 March 2008
Peppol
Active · Active since 31 May 2024
Activities · NACE

Detailhandel in farmaceutische producten

Frequently asked questions

What does ESPIDEC do?
ESPIDEC is a pharmacy in Sint-Genesius-Rode. Private Limited, started on 31 March 2008, 1 establishment.
What is the address of ESPIDEC?
The registered office of ESPIDEC is located at Zoniënwoudlaan 361, 1640 Sint-Genesius-Rode.
Is ESPIDEC still active?
Yes. According to the CBE (16 September 2026) ESPIDEC is active, legal situation “Normale toestand”, started on 31 March 2008.
Is ESPIDEC registered on Peppol?
Yes, ESPIDEC is registered on the Peppol network with ID 0208:0896802612.
What is the enterprise number of ESPIDEC?
The enterprise number of ESPIDEC is BE0896802612.
When was ESPIDEC founded?
ESPIDEC was founded on 31 March 2008.